高盛：中国韧性 - 茅台和 CATL、中国宏观、中国医疗保健、美国战略
高盛证券·2024-10-11 14:13
7 October 2024 | 7:21AM HKT The 720: Asia Strategy, China Resilience - Moutai & CATL, China Macro, China Healthcare, US Strategy In Focus | Asia Strategy Asia Strategy - China changes the game. We raise China to overweight tactically and increase our MXAPJ 12m index target to 690 on higher earnings and valuations. The current rally has brought the MSCI China forward P/E to 11.3x (-0.4 s.d.). Valuation could expand to 12x on policy support. We raise our 12m MXCN/CSI300 targets to 84/4600 implying 15-18% upsi ...